These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31897728)

  • 1. The effects of chronic subthalamic stimulation on nonmotor symptoms in advanced Parkinson's disease, revealed by an online questionnaire program.
    Kawaguchi M; Samura K; Miyagi Y; Okamoto T; Yamasaki R; Sakae N; Yoshida F; Iihara K
    Acta Neurochir (Wien); 2020 Feb; 162(2):247-255. PubMed ID: 31897728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial nonmotor effects of subthalamic and pallidal neurostimulation in Parkinson's disease.
    Dafsari HS; Dos Santos Ghilardi MG; Visser-Vandewalle V; Rizos A; Ashkan K; Silverdale M; Evans J; Martinez RCR; Cury RG; Jost ST; Barbe MT; Fink GR; Antonini A; Ray-Chaudhuri K; Martinez-Martin P; Fonoff ET; Timmermann L;
    Brain Stimul; 2020; 13(6):1697-1705. PubMed ID: 33038595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.
    Dafsari HS; Martinez-Martin P; Rizos A; Trost M; Dos Santos Ghilardi MG; Reddy P; Sauerbier A; Petry-Schmelzer JN; Kramberger M; Borgemeester RWK; Barbe MT; Ashkan K; Silverdale M; Evans J; Odin P; Fonoff ET; Fink GR; Henriksen T; Ebersbach G; Pirtošek Z; Visser-Vandewalle V; Antonini A; Timmermann L; Ray Chaudhuri K;
    Mov Disord; 2019 Mar; 34(3):353-365. PubMed ID: 30719763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease.
    Witjas T; Kaphan E; Régis J; Jouve E; Chérif AA; Péragut JC; Azulay JP
    Mov Disord; 2007 Sep; 22(12):1729-34. PubMed ID: 17557355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, controlled study of non-motor effects of subthalamic stimulation in Parkinson's disease: results at the 36-month follow-up.
    Jost ST; Sauerbier A; Visser-Vandewalle V; Ashkan K; Silverdale M; Evans J; Loehrer PA; Rizos A; Petry-Schmelzer JN; Reker P; Fink GR; Franklin J; Samuel M; Schnitzler A; Barbe MT; Antonini A; Martinez-Martin P; Timmermann L; Ray-Chaudhuri K; Dafsari HS;
    J Neurol Neurosurg Psychiatry; 2020 Jul; 91(7):687-694. PubMed ID: 32371534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate effects of deep brain stimulation of the subthalamic nucleus on nonmotor symptoms in Parkinson's disease.
    Wolz M; Hauschild J; Koy J; Fauser M; Klingelhöfer L; Schackert G; Reichmann H; Storch A
    Parkinsonism Relat Disord; 2012 Sep; 18(8):994-7. PubMed ID: 22682974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contacts.
    Dafsari HS; Petry-Schmelzer JN; Ray-Chaudhuri K; Ashkan K; Weis L; Dembek TA; Samuel M; Rizos A; Silverdale M; Barbe MT; Fink GR; Evans J; Martinez-Martin P; Antonini A; Visser-Vandewalle V; Timmermann L; ;
    Brain Stimul; 2018; 11(4):904-912. PubMed ID: 29655586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease.
    Dafsari HS; Silverdale M; Strack M; Rizos A; Ashkan K; Mahlstedt P; Sachse L; Steffen J; Dembek TA; Visser-Vandewalle V; Evans J; Antonini A; Martinez-Martin P; Ray-Chaudhuri K; Timmermann L;
    Mov Disord; 2018 Mar; 33(3):421-430. PubMed ID: 29465787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson's disease.
    Dafsari HS; Weiß L; Silverdale M; Rizos A; Reddy P; Ashkan K; Evans J; Reker P; Petry-Schmelzer JN; Samuel M; Visser-Vandewalle V; Antonini A; Martinez-Martin P; Ray-Chaudhuri K; Timmermann L;
    Brain Stimul; 2018; 11(4):867-874. PubMed ID: 29655587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of subthalamic deep brain stimulation on non-motor symptoms of Parkinson's disease: A meta-analysis.
    Eghlidos Z; Rahimian Z; Vadiee G; Jahangiri S
    Acta Neurol Scand; 2022 Aug; 146(2):115-125. PubMed ID: 35611557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor and nonmotor symptom follow-up in parkinsonian patients after deep brain stimulation of the subthalamic nucleus.
    Zibetti M; Torre E; Cinquepalmi A; Rosso M; Ducati A; Bergamasco B; Lanotte M; Lopiano L
    Eur Neurol; 2007; 58(4):218-23. PubMed ID: 17823535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Subthalamic Deep Brain Stimulation on Restless Legs Syndrome in Parkinson's Disease.
    Dulski J; Wąż P; Konkel A; Grabowski K; Libionka W; Schinwelski M; Sitek EJ; Sławek J
    Neuromodulation; 2022 Aug; 25(6):904-910. PubMed ID: 34036673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
    Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
    Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
    Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T
    Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonmotor Symptoms and Subthalamic Deep Brain Stimulation in Parkinson's Disease.
    Kim HJ; Jeon BS; Paek SH
    J Mov Disord; 2015 May; 8(2):83-91. PubMed ID: 26090080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.
    Kim HJ; Paek SH; Kim JY; Lee JY; Lim YH; Kim DG; Jeon BS
    Mov Disord; 2009 Feb; 24(3):329-35. PubMed ID: 19006187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive potential of preoperative electroencephalogram for neuropsychological change following subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Yakufujiang M; Higuchi Y; Aoyagi K; Yamamoto T; Abe M; Okahara Y; Izumi M; Nagano O; Yamanaka Y; Hirano S; Shiina A; Murata A; Iwadate Y
    Acta Neurochir (Wien); 2019 Oct; 161(10):2049-2058. PubMed ID: 31278598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensorimotor subthalamic stimulation restores risk-reward trade-off in Parkinson's disease.
    Irmen F; Horn A; Meder D; Neumann WJ; Plettig P; Schneider GH; Siebner HR; Kühn AA
    Mov Disord; 2019 Mar; 34(3):366-376. PubMed ID: 30485537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.